Ardelyx, Inc

Solomon1983

Following the negative news that sent this stock into an 82% tailspin there is no viable buy signal aside from a simple long-term play. Trend is continuing downward slowly. Has yet to find a solid support zone. By way of Analyst Consensus, upside is above 100% but may take 12-months to materialize. By way of previous share price average, upside is close to...

eulenman

The current falling wedge in 1H has absolute bottom of 1.69$. If the bulls manage to break this wedge things can get interesting.

Thatsir

Entered @ 2.00 but hard to pass that up

CryptoFundManager

The FDA is unlikely to approve Ardelyx`s drug for dialysis patients. Ardelyx received a letter from the FDA stating that deficiencies in the information provided had been found that would preclude discussion of approvals Ardelyx has sought. The most likely target is the 1.6usd support line from which it can bounce up.

Okipanese

This is not financial advice. This thesis is exclusively based on technical analysis without catalyst. Bullish trend expected to continue and hit new highs as long as volume is high. Stop loss set at closest support.

majesticsteve

$12 gap fill July 29

jguerr04

Bullish, remember... always add your stop loss

ProjectSyndicate

Why get subbed to to me on Tradingview? -TOP author on TradingView -15+ years experience in markets -Professional chart break downs -Supply/Demand Zones -TD9 counts / combo review -Key S/R levels -No junk on my charts -Frequent updates -Covering FX/crypto/US stocks -24/7 uptime so constant updates ARDX D1::BEST level to BUY 100% gains (SWING)(STOCKS) IMPORTANT...

Petergalaby

This is not financial advise you do what is make you feeling comfort ARDX will easy hit Short Term : TG1 $7 Long term : TG2 $7.57 TG3 $8.05 if you like me advise follow me thanks for your support

Petergalaby

This is not financial advise you do what is make you feeling comfort ARDX will easy hit Short Term : T1 $7 Long term : T2 $7.57 T3 $8.05 GOOD LUCK

Petergalaby

This is not financial advise you do what is make you feeling comfort ARDX will easy hit Short Term : T1 $7 Long term : T2 $7.57 T3 $8.05 if you like me advise follow me thanks for your support

Petergalaby

This is not financial advise you do what is make you feeling comfort ARDX will easy hit Short Term : TG1 $7 Long term : TG2 $7.57 TG3 $8.05 if you like me advise follow me thanks for your support

horridmar

Simple Moving Averages indicate a bearish pattern. Trend line has been broken.

RocketTickers

ARDX: Ardelyx 2020-06-15 08:00:00 Ardelyx Announces Positive Second Data Analysis from Ongoing NORMALIZE Phase 4 Study Evaluating Tenapanor in CKD Patients on Dialysis

RocketTickers

ARDX: Ardelyx 2019-12-03 07:25:00 Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialysis

InsiderFinancial

After breaking to higher ground a week ago on enormous volume, shares of ARDELYX INC - NASDAQ: ARDX find themselves in constructive consolidation mode digesting the recent run on lower volume as we can observe from the Daily chart above. With the stock trading well above its 20/50 and 200 DMA's on the Daily timeframe, the short-term technical posture of ARDX ...

DT-21

05:13 Piper still sees 'substantial upside' in Ardelyx despite last week's rally Piper Jaffray analyst Christopher Raymond says he still expects "substantial upside" in shares of Ardelyx even after last week's 43% move. While Amplify's more "real world" representation assuaged the key investor concern around tenapanor's adverse event-related discontinuations,...

PennyStock101

Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of renal diseases. It focuses on the formulation of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipation. Its product portfolio includes tenapanor, which is an experimental...